Bullet Biotechnology's Series A Round

Bullet Biotechnology raised a round of funding on February 08, 2012. Investors include Accel.

Bullet Bio is developing an active immunotherapy to stimulate a person's own immune system to fight disease. The company's product trains the immune system to target a unique marker present on all B c…

Articles about Bullet Biotechnology's Series A Round: